PHARMIGENE

Pharmigene was founded in 2005 by venture capital firms and individuals. Our goal is to innovate and commercialize diagnostic tests that enable individuals to be better informed about their genomic makeup and make decisions that better their health. We have licensed exclusive worldwide rights and transferred essential know-how from Academia Sinica relating to the genetic markers associated with adverse drug reactions caused by several popular drugs... PharmiGene., Inc MEDICA 2022, the world-leading information and communication platform for the medical technology industry and supplier industry, will take place to live in Düsseldorf. Pharmigene, as the global leader in pharmacogenetic tests, will bring

Also known as: Pharmigene, Inc.

Registration numbers: LDT0010 (W), LDT00100 (W)

Primary location: Hub Singapore